Supplementary figure 2 from WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
Year: 2023
Type: supplementary-materials
Abstract: Progression Free survival in metastatic CRC patients with unmethylated or methylated WRN promoter regions, in response to second line irinotecan (IRI) treatment in the sequential treatment arm (arm A).
Authors: Linda J.W. Bosch, Yanxin Luo, Victoria V. Lao, Petur Snaebjornsson, Geert Trooskens, Ilse Vlassenbroeck, Sandra Mongera, Weiliang Tang, Piri Welcsh, James G. Herman, Miriam Koopman, Iris D. Nagtegaal, Cornelis J.A. Punt, Wim van Criekinge, Gerrit A. Meijer, Raymond J. Monnat, Beatriz Carvalho, William M. Grady
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361909893